QTTB:NASDAQ, Q32 Bio Inc.

QTTB stock overview

Q32 Bio Inc. (QTTB:NASDAQ) closed at $8.71 on November 13, 2026, down 1.25% on the day. The stock trades 63.0% below its 52-week high of $23.57 and 357.2% above its 52-week low of $1.91. Over the past year, it gained 280.3%. Q32 Bio Inc. is part of the Health Care sector.

Key figures

Price
$8.71
Day change
-1.25%
Volume
243,793
Average volume
687,446
Market cap
260M+
52-week range
$1.91 – $23.57
50-day average
$9.30
200-day average
$9.47

Price action over the past year

In 252 trading sessions since November 13, 2025, QTTB closed higher on 117 days (46%). Its best day was July 13, 2026 (+90.72%) and its worst was May 28, 2026 (-19.77%). The stock moved 10% or more in a single session 23 times. It opened at least 5% above the previous day's high 4 times.

Recent signals

QTTB news

About Q32 Bio Inc.

Homology Medicines Inc is a US-based genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases with significant unmet medical needs by curing the underlying cause of the disease. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing modality across a range of genetic disorders.

Similar stocks

Find more stocks like QTTB with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.